Antispam
CyTuVax is currently testing its vaccine technology in a clinical Phase 2 study of a vaccine for hepatitis B non-responders
CyTuVax B.V.Oxfordlaan 55 6229 EV MaastrichtThe Netherlands
+31-433881424Contact us by email
CyTuVax is currently testing its vaccine technology in a clinical Phase 2 study of a vaccine for hepatitis B non-responders